• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Pseudopseudohypoparathyroidism

Article

A 13-year-old girl was notably short and had short fourth metacarpals and metatarsals. She was very mildly mentally retarded.

A 13-year-old girl was notably short and had short fourth metacarpals and metatarsals. She was very mildly mentally retarded.

Levels of serum calcium were 2.44 mmol/L; phosphate, 1.68 mmol/L; alkaline phosphatase, 231 U/L, and parathyroid hormone, 4 pg/mL. Skull films showed calcification of the basal ganglia. Dr Alexander K. C. Leung of Calgary, Alberta, made the diagnosis of pseudopseudohypoparathyroidism.

Dr Leung comments that patients with pseudopseudohypoparathyroidism and patients with pseudohypoparathyroidism have the same clinical stigmata-short stature, short fourth metacarpals and metatarsals, round face, mild to moderate mental retardation, subcutaneous calcification, and calcification of the basal ganglia. However, persons with pseudohypoparathyroidism also have end-organ resistance to parathyroid hormone, and thus have hypocalcemia, hyperphosphatemia, and elevated parathyroid hormone levels. In contrast, patients such as this adolescent with pseudopseudohypoparathyroidism have normal serum calcium, phosphate, and parathyroid hormone levels.

Related Videos
Donna H Ryan, MD Obesity Expert Highlights 2021 Research Success and Looks to 2022 and Beyond
© 2024 MJH Life Sciences

All rights reserved.